NMN may restore bone loss from aluminum toxicity

NMN may restore bone loss from aluminum toxicity

Scientists from China provide evidence: nicotinamide mononucleotide (NMN) treatment restores bone loss from aluminum consumption in rats. 


Aluminum, an environmental contaminant, can have toxic effects on the brain, bones, liver, and kidneys.4,8,11  Medicines, cosmetic products, and food additives can contain aluminum.8,10  Acid rain has also mobilized aluminum from soil, making aluminum exposure through water and food products more prevalent.4  Approximately 50-70% of aluminum entering the body accumulates in the bone, a primary target for aluminum toxicity.7,8  Exposure of bone to aluminum results in bone impairment and disruption of bone formation, causing bone diseases such as osteoporosis, osteodystrophy, and osteomalacia.1,8

The molecular mechanism of aluminum-induced bone toxicity remains unclear.8  Previous studies indicate oxidative stress and inflammation contribute to bone toxicity and bone disease progression.3,8,9  Inhibiting oxidative stress and inflammation could prevent bone loss associated with bone toxicity.2,8,14

Studies indicate the precursor of nicotinamide adenine dinucleotide (NAD+) biosynthesis, NMN, provides an effective therapy for improving intracellular NAD+ levels.8,13,15  Previous studies demonstrate decreased NAD+ levels associate with osteoblastogenesis, declined generation of bone cells.  The present study investigates whether NMN supplementation of rats has protective benefits in aluminum-induced bone damage.  The study also seeks evidence for the cellular pathways involved.

Fig. 1

Image from Liang et al. (2019).  In the image above, the top row has pictures looking at the top (epiphysis) of the femur bone, while the bottom row has pictures of the shaft (diaphysis) of the bone, taken with micro-CT imaging.

Results from experimentation indicate NMN treatment counteracts aluminum-induced bone impairment.  The experiments demonstrate NMN supplementation restores reduced NAD+ levels in cells. Rats undergoing aluminum exposure treated with NMN have restored bone integrity.

Fig. 2

Image from Liang et al. (2019).  The images above represent data collected in these experiments.  They indicate ALP activity ecreases with exposure to aluminum.

Experimental results also indicate NMN treatment effectively alleviates aluminum-induced bone loss.   ALP, an enzyme present at higher levels when bone grows, has increased levels after aluminum exposure with NMN treatment.  NMN supplementation also restores BGP levels, an indicator for new bone formation, following aluminum exposure Researchers also tracked the level of TRACP-5b and CTX-1, which are markers that indicate bone breakdown in high levels. With NMN administration following aluminum exposure, both levels decrease. 

Results from further experimentation in the study reveal aluminum-treated bone cells have higher levels of oxidative stress compared to cells without aluminum treatment.  NMN treatment reduces the oxidative stress as measured with reactive oxygen species levels. Results also demonstrate NMN treatment inhibits cells involved in inflammatory responses in bone cells exposed to aluminum.

The results of the study demonstrate NMN can counteract adverse effects on bone of aluminum exposure.  Humans may receive exposure to the inorganic contaminant, aluminum, through drinking water and food.5,8  Previous studies indicate oxidative stress, inflammation, bone impairment, and increased risk of osteoporosis result from aluminum exposure.8,12

The effects of NMN administration on bone impairment from aluminum exposure remains poorly understood based on previous studies.  The results point to NMN treatment improving bone mineral density and structural properties receiving injury from aluminum exposure.  NMN treatment also reduces oxidative stress from aluminum exposure, according to data from the study. The NMN treatment reduces expression of inflammation through inhibition of inflammasome activation.  “NAD+ depletion might underlie [aluminum]-induced toxicity, whereas NMN may protect against [aluminum]-induced bone impairment via inhibiting the TXNIP-NLRP3 inflammasome pathway,” according to the authors of the study. The findings of the study provide new insight for using NMN to counteract aluminum toxicity.

  1. Haipeng Liang, Jian Gao, Chi Zhang, Chunlin Li, Qi Wang, Jiaojiao Fan, Zizheng Wu, Qiugen Wang.  Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasomeToxicol Appl Pharmacol, 2019; DOI: 10.1016/j.taap.2018.10.006.
  1. Jan Aaseth, Georges Boivin, Ole Andersen.  Osteoporosis and trace elements – An overviewJ Trace Elem Med Biol, 2012; DOI: 10.1016/j.jtemb.2012.03.017.
  2. Joanna Trycia M. Alexandre, Luzia Herminia Teixeira Sousa, Mario Roberto Pontes Lisboa, Flavia A.C. Furlaneto, Danielle Rocha do Val, Mirna Marques, Helliada C. Vasconcelos, Iracema Matos de Melo, Renata Leitao, Gerly Anne Castro Brito, Paula Goes.  Anti-inflammatory and antiresorptive effects of Calendula officinalis on inflammatory bone loss in ratsClin Oral Investig, 2017; DOI: 10.1007/s00784-017-2308-7.
  3. Zheng Cao, Xu Yang, Haiyang Zhang, Haoran Wang, Wanyue Huang, Feibo Xu, Cuicui Zhuang, Xiaoguang Wang, Yanfei Li.  Aluminum chloride induces neuroinflammation, loss of neuronal dendritic spine and cognition impairment in developing ratChemosphere, 2016; DOI: 10.1016/j.chemophere.2016.02.092.
  4. Guido Crisponi, Daniela Fanni, Clara Gerosa, Sonia Nemolato, Valeria M. Nurchi, Miriam Crespo-Alonso, Joanna I. Lachowicz, Gavino Faa.  The meaning of aluminium exposure on human health and aluminium-related diseases.  Biomol Concepts, 2013; DOI: 10.1515/bmc-2012-0045.
  5. Madjid Djouina, Nicolas Esquerre, Pierre Desreumaux, Cecile Vignal, Mathilde Body-Malapel.  Toxicological consequences of experimental exposure to aluminum in human intestinal epithelial cellsFood Chem Toxicol, 2016; DOI: 10.1016/j.fct.2016.03.008.
  6. F. Ismail, S. Epstein, R. Pacifici, D. Droke, S.B. Thomas, L.V. Avioli.  Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosisCalcif Tissue Int, 1986; 39(4): 230-3.
  7. Xinwei Li, Lichao Zhang, Yanzhu Zhu, Yanfei Li.  Dynamic analysis of exposure to aluminum and an acidic condition on bone formation in young growing ratsEnviron Toxicol Pharmacol, 2011; DOI: 10.1016/j.etap.2010.11.007.
  8. Haipeng Liang, Jian Gao, Chi Zhang, Chunlin Li, Qi Wang, Jiaojiao Fan, Zizheng Wu, Qiugen Wang.  Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasomeToxicol Appl Pharmacol, 2019; DOI: 10.1016/j.taap.2018.10.006.
  9. Shaoshan Mai, Qin He, Hong Wang, Xinyue Hu, Ying Luo, Yang Yang, Shengnan Kuang, Xiaoyan Tian, Jie Ma, Junqing Yang.  5-lipoxygenase activation is involved in the mechanisms of chronic hepatic injury in a rat model of chronic aluminum overload exposureToxicol Appl Pharmacol, 2016; DOI: 10.1016/j.taap.2016.06.029.
  10. Diana Ribes, M. Teresa Colomina, Paloma Vicens, Jose Domingo.  Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer’s diseaseExp Neurol, 2008; DOI: 10.1016/j.expneurol.2008.08.017.
  11. Virgilia S. Silva & Paula P. Goncalves.  Effect of lysine acetylsalicylate on aluminium accumulation and (Na+/K+)ATPase activity in rat brain cortex synaptosomes after aluminium ingestion.  Toxicol Lett, 2015; DOI: 10.1016/j.toxlet.2014.10.014.
  12. Xudong Sun, Jianyu Liu, Ciuciu Zhuang, Xu Yang, Yanfei Han, Bing Shao, Miao Song, Yanfei Li, Yanzhu Zhu.  Aluminum trichloride induces bone impairment through TGF-beta1/Smad signaling pathwayToxicology, 2016; DOI: 10.1016/j.tox.2016.10.002.
  13. Chun-Chun Wei, Yuan-Yuan Kong, Guo-Qiang Li, Yun-Feng Guan, Pei Wang, Chao-Yu Miao.  Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathwaySci Rep, 2017; DOI: 1.1038/s41598-017-00851-z.
  14. Lu Zhao, Yin Wang, Zejian Wang, Zheng Xu, Qiaoyan Zhang, Ming Yin.  Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative characterJ Nutr Biochem, 2015; DOI: 10.1016/j.jnutbio.2015.05.009.
  15. Can-Can Zhou, Xi Yang, Xia Hua, Jian Liu, Mao-Bing Fan, Guo-Qiang Li, Jie Song, Tian-Ying Xu, Zhi-Yong Li, Yun-Feng Guan, Pei Wang, Chao-Yu Miao.  Hepatic NAD+ deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageingBr J PHarmacol, 2016; DOI: 10.1111/bph.13513.